Physician
Rene, Daniel
Rene, Daniel was paid $459K by Medicaid between Apr 2018 and Mar 2023, across 20 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 34% of everything it billed.
33Billing provider infoRENE, DANIEL
PEABODY, MA 01960
PEABODY, MA 01960
33aNPI1316386717assigned 06/19/2013
33bProvider typePediatrics Physician
28Total paid$459K
24GClaims10,741
24DCodes billed20
24AFirst – last monthApr 2018 – Mar 2023
Compared with peers
Next to other Pediatrics Physician providers in Massachusetts
Rank by total paid#163 of 1,273
Median peer was paid$24K
This provider vs. median19×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 885 | $35K | |
| 2019 | 1,615 | $67K | |
| 2020 | 1,610 | $65K | |
| 2021 | 2,901 | $123K | |
| 2022 | 2,771 | $124K | |
| 2023 | 959 | $45K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 34% | 2,736 | 2,699 | $157K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 25% | 1,183 | 1,168 | $116K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 12% | 1,058 | 1,045 | $54K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 8.2% | 1,056 | 892 | $38K |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 4.8% | 872 | 857 | $22K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 4.2% | 240 | 239 | $19K |
| 99050 | 2.7% | 736 | 734 | $12K | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 2.3% | 347 | 347 | $11K |
| S0302 | Completed early periodic screening diagnosis and treatment (epsdt) service (list in addition to code for appropriate evaluation and management service) | 2.2% | 1,127 | 1,125 | $10K |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 387 | 372 | $4K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | <1% | 42 | 42 | $3K |
| 96127 | <1% | 327 | 327 | $3K |
8 more codes
| 90461 | <1% | 85 | $3K | |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 25 | $2K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | <1% | 14 | $1K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 42 | $858.90 |
| 94760 | <1% | 318 | $696.19 | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 79 | $568.15 |
| 36416 | <1% | 54 | $540.00 | |
| 80061 | Lipid panel | <1% | 13 | $153.53 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.